Warning letters
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplements purporting to cure diseases ranging from Alzheimer's to bird flu are the topic of three warning letters sent by FDA in January. In the letters, FDA addresses claims for Long Life Catalog Company's supplement Zap-V, Robert Davis' All-Natural Interferon and Trim International's TCR Cell Rejuvenator. Specifically, FDA takes issue with Zap-V's claims that the product reduces inflammation and acts as an "anticancer, anti-tumor, antiviral" medication, according to the Jan. 30 letter. In Jan. 24 correspondence, the agency targets claims made to promote All-Natural Interferon as "an immune system booster." Finally, in a Jan. 9 letter, the agency addresses claims that TCR Cell Rejuvenator "helps prevent recurrent herpes, common cold and flu, and is used to treat patients with Alzheimer's, Parkinson's, cancer and other infectious diseases and neurological disorders." All the claims are found on the individual products' web sites, according to FDA...
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.